Patients in England and Wales with cardiomyopathy caused by the disorder ATTR amyloidosis will soon be able to access treatment with Alnylam's gene-silencing drug Amvuttra. The ruling by reimbursement ...

Charity hails ‘momentous’ decision to give abiraterone to about 8,000 newly diagnosed men each year The NHS has expanded access to a prostate cancer drug across England in a move expected to save ...

NICE has backed NHS use of natalizumab, a key treatment option that is safe for use in pregnancy, for more patients with multiple sclerosis. NICE has said Biogen's Tysabri can now be used by the NHS ...

Thousands more men with prostate cancer will be eligible for a life-extending drug on the NHS. The move means the drug, known as abiraterone, will be available for the first time to patients whose ...

Thousands of men battling prostate cancer are set to receive a life-extending medication on the NHS, following a three-year campaign to broaden access. Abiraterone, which works by halting testosterone ...

Treatment that can halve risk of dying will be made available to more than 7,000 more men a year Laura Donnelly is the Health Editor for The Telegraph, leading award-winning coverage on the NHS, ...

THOUSANDS more men will get a life-saving prostate cancer drug on the NHS in a win for The Sun after we revealed the deadly postcode lottery. NHS England said an extra 7,000 blokes per year will now ...

The NHS has expanded access to a prostate cancer drug across England in a move which could stop 8,000 former cancer patients from being told their illness has returned. Currently only those with ...

The Emirates Drug Establishment (EDE) announced that an additional product, S26 AR, has been included in the scope of the voluntary and precautionary recall of Nestlé infant formula, which is intended ...

People taking a commonly prescribed medication have been urged to "call 111" if they experience certain symptoms. These "serious" side effects necessitate immediate medical intervention. Diltiazem is ...

The Institute of Cancer Research, London has welcomed the announcement by NHS England that the lifesaving drug abiraterone has been approved for use on the NHS for men in England with prostate cancer ...